Loading...

SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Management Changes 8-K Filing

SHTT

SHPH

SHUTTLE PHARMACEUTICALS HOLDINGS INC

(SHPH)

FY2023 8 K

SHTT

SHPH

SHUTTLE PHARMACEUTICALS HOLDINGS INC

(SHPH)

FY2023 8 K

Filing:

8 K

Published on:

3 May '23

Investor Presentation

Patent Application

Consulting Agreement

Management Restructuring

Consulting Agreement

Public Offering

Management Change

Agreement Amendment

Corporate Update

Study Expansion

Clinical Trial Update

Nasdaq Compliance

Research Agreement

Clinical Trial Update

Corporate Update

Clinical Trial Update

Clinical Trial Update

Investor Conference

Nasdaq Compliance Issue

Promissory Note Issued

Nasdaq Compliance

Nasdaq Compliance

Clinical Trial Agreement

Amendment Agreement and Rev...

Annual Meeting Results

Accounting Errors

Appointment of CFO

Investor Conferences

Earnings Reports

Investor Conferences

CEO Participation in MicroC...

Earnings Update

Securities Purchase Agreeme...

Asset Purchase Agreement an...

FDA Approval for Phase II S...

CEO Conference Participation

Earnings Update

Licensing Agreement

Investor Conferences

Consulting Agreement with J...

Earnings Reports

Manufacturing Success and F...

Amendment Agreement

Results of Operations and F...

Conference Participation

Amendment Agreement with Al...

Bonus Awarded to CEO

Research Agreement with Geo...

Agreement with University o...

Lease Agreement and Directo...

CEO Presentation at Investo...

Entry Into A Material Defin...

External Links:

AI Assistant

SHUTTLE PHARMACEUTICALS HOLDINGS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.